$11.80 per share offer rejected as Challenger seeks better proposal

Board Rejects $11.80 Takeover Price

Challenger Limited (ASX:CGF) has rejected TAL Daiichi Life Australia’s $11.80-per-share approach, drawing a line under the current price without closing the door on a deal. After considering Challenger’s value and prospects, the board concluded the indicative offer was not at a level it could recommend to shareholders.

The response leaves the takeover proposal in an awkward middle ground: rejected in its present form, but still alive. The company said it values TAL as its largest shareholder and commercial partner, and intends to engage with TDA to determine whether a proposal could be reached that the board would support.

TAL’s Conditional Proposal Remains Non-Binding

The offer, first disclosed on 19 October, seeks to acquire the ordinary shares TAL does not already own through a scheme of arrangement. The earlier approach was a $11.80 per share offer and was described as conditional and non-binding.

That distinction matters. Challenger has not disclosed a revised price, the terms of any potential improved proposal, or the valuation level it would consider acceptable. The company also stressed that there is no certainty discussions will produce a binding offer, or that any transaction will ultimately eventuate.

Next Test Is Whether Talks Produce a Higher Bid

For shareholders, the immediate question is not whether the current offer will proceed: the board has made clear it cannot recommend that price. The more consequential question is whether TAL responds with a revised proposal that changes the board’s assessment, and whether any such offer would then move into a formal scheme process.

Until that happens, the proposal remains a negotiation rather than a transaction. Challenger said shareholders do not need to take any action at this time, leaving the next material signal to come from the discussions between the two parties.